Craig R. Stumpf

3.2k total citations · 1 hit paper
23 papers, 2.0k citations indexed

About

Craig R. Stumpf is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Craig R. Stumpf has authored 23 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Craig R. Stumpf's work include RNA and protein synthesis mechanisms (9 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (7 papers). Craig R. Stumpf is often cited by papers focused on RNA and protein synthesis mechanisms (9 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (7 papers). Craig R. Stumpf collaborates with scholars based in United States, India and Germany. Craig R. Stumpf's co-authors include Davide Ruggero, Andrew C. Hsieh, Pingda Ren, Jonathan S. Weissman, Nicholas T. Ingolia, Matthew R. Janes, Michael Bonham, Shunyou Wang, Michael Martin and Morris E. Feldman and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Craig R. Stumpf

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The translational landscape of mTOR signalling steers cancer initiation and metastasis

2012 978 citations Andrew C. Hsieh, Yi Liu et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig R. Stumpf United States	13	1.7k	210	196	157	124	23	2.0k
Gretchen Poortinga Australia	18	1.7k 1.0×	336 1.6×	149 0.8×	144 0.9×	149 1.2×	31	2.0k
Yuzuru Shiio United States	21	1.5k 0.9×	364 1.7×	292 1.5×	154 1.0×	161 1.3×	34	1.9k
Elena Zelin United States	13	1.1k 0.6×	157 0.7×	237 1.2×	167 1.1×	151 1.2×	14	1.4k
Sergei Chuikov United States	11	2.3k 1.4×	408 1.9×	176 0.9×	105 0.7×	212 1.7×	15	2.6k
Caroline Schild‐Poulter Canada	23	1.1k 0.6×	292 1.4×	127 0.6×	124 0.8×	161 1.3×	43	1.3k
Martina Rath Austria	15	2.1k 1.2×	260 1.2×	261 1.3×	189 1.2×	329 2.7×	20	2.6k
Wenjian Gan United States	21	1.7k 1.0×	325 1.5×	317 1.6×	150 1.0×	151 1.2×	34	2.0k
Rosa Luna Spain	24	1.7k 1.0×	360 1.7×	213 1.1×	169 1.1×	150 1.2×	40	2.0k
Fabrizio Loreni Italy	30	1.7k 1.0×	248 1.2×	192 1.0×	119 0.8×	157 1.3×	58	2.0k
Elizaveta V. Benevolenskaya United States	21	1.1k 0.6×	269 1.3×	211 1.1×	90 0.6×	100 0.8×	35	1.3k

Countries citing papers authored by Craig R. Stumpf

Since Specialization

Citations

This map shows the geographic impact of Craig R. Stumpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig R. Stumpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig R. Stumpf more than expected).

Fields of papers citing papers by Craig R. Stumpf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig R. Stumpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig R. Stumpf. The network helps show where Craig R. Stumpf may publish in the future.

Co-authorship network of co-authors of Craig R. Stumpf

This figure shows the co-authorship network connecting the top 25 collaborators of Craig R. Stumpf. A scholar is included among the top collaborators of Craig R. Stumpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig R. Stumpf. Craig R. Stumpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parker, Gregory S., Julia I. Toth, Sarah Fish, et al.. (2024). Discovery of Monovalent Direct Degraders of BRD4 that Act via the Recruitment of DCAF11. Molecular Cancer Therapeutics. 23(10). 1446–1458. 3 indexed citations

Gerson‐Gurwitz, Adina, Nathan P. Young, Vikas Goel, et al.. (2021). Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven Tumors. Frontiers in Oncology. 11. 766298–766298. 22 indexed citations

Peña, June Bryan de la, Jonathan E. Ploski, Craig R. Stumpf, et al.. (2020). A Highly Selective MNK Inhibitor Rescues Deficits Associated with Fragile X Syndrome in Mice. Neurotherapeutics. 18(1). 624–639. 13 indexed citations

Thompson, Peggy A., Nathan P. Young, Craig R. Stumpf, et al.. (2019). Abstract B133: eFT226, a first in class inhibitor of eIF4A1, targets FGFR1/2 and HER2 driven cancers. Molecular Cancer Therapeutics. 18(12_Supplement). B133–B133. 3 indexed citations

Goel, Vikas, Rajesh Sharma, Jocelyn Staunton, et al.. (2019). Abstract LB-068: Tomivosertib (eFT508), a potent and highly selective inhibitor of MNK1 and MNK2, enhances CAR T cell activity through modulating T cell differentiation. Cancer Research. 79(13_Supplement). LB–68.

Stumpf, Craig R., Joan Chen, Vikas Goel, et al.. (2018). Abstract 3855: Inhibition of MNK by eFT508 reprograms T-cell signaling to promote an antitumor immune response. Cancer Research. 78(13_Supplement). 3855–3855. 4 indexed citations

Webster, Kevin R., Vikas Goel, Jocelyn Staunton, et al.. (2017). Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade. Cancer Research. 77(6_Supplement). PR11–PR11. 3 indexed citations

Webster, Kevin R., Vikas Goel, Jocelyn Staunton, et al.. (2017). Abstract 596: eFT508, a potent and highly selective inhibitor of MNK1/2 regulates immune checkpoint and cytokine expression promoting anti-tumor immunity. Cancer Research. 77(13_Supplement). 596–596. 3 indexed citations

Stumpf, Craig R., et al.. (2013). The Translational Landscape of the Mammalian Cell Cycle. Molecular Cell. 52(4). 574–582. 165 indexed citations

10.

Stumpf, Craig R., et al.. (2013). Abstract A57: Plasticity of the translational landscape during the mammalian cell cycle: Implications and new insights for cancer cell proliferation. Cancer Research. 73(19_Supplement). A57–A57. 1 indexed citations

11.

Cunningham, John T., Michael Pourdehnad, Craig R. Stumpf, & Davide Ruggero. (2013). Investigating Myc-Dependent Translational Regulation in Normal and Cancer Cells. Methods in molecular biology. 1012. 201–212. 5 indexed citations

12.

Stumpf, Craig R., et al.. (2012). Context-dependent function of a conserved translational regulatory module. Development. 139(8). 1509–1521. 21 indexed citations

13.

Hsieh, Andrew C., Yi Liu, Nicholas T. Ingolia, et al.. (2012). The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 485(7396). 55–61. 978 indexed citations breakdown →

14.

Pusic, Aya D., Craig R. Stumpf, Kunihiko Shimizu, et al.. (2011). Ribosome-Mediated Specificity in Hox mRNA Translation and Vertebrate Tissue Patterning. Cell. 145(3). 383–397. 423 indexed citations

15.

Stumpf, Craig R. & Davide Ruggero. (2011). The cancerous translation apparatus. Current Opinion in Genetics & Development. 21(4). 474–483. 88 indexed citations

16.

Opperman, Laura, et al.. (2009). A single C. elegans PUF protein binds RNA in multiple modes. RNA. 15(6). 1090–1099. 37 indexed citations

17.

Zhu, Deyu, Craig R. Stumpf, Joseph M. Krahn, Marvin Wickens, & Traci M. Tanaka Hall. (2009). A 5′ cytosine binding pocket in Puf3p specifies regulation of mitochondrial mRNAs. Proceedings of the National Academy of Sciences. 106(48). 20192–20197. 70 indexed citations

18.

Stumpf, Craig R., Laura Opperman, & Marvin Wickens. (2008). Analysis of RNA–Protein Interactions Using a Yeast Three-Hybrid System. Methods in enzymology on CD-ROM/Methods in enzymology. 449. 295–315. 22 indexed citations

19.

Stumpf, Craig R., Judith Kimble, & Marvin Wickens. (2008). A Caenorhabditis elegans PUF protein family with distinct RNA binding specificity. RNA. 14(8). 1550–1557. 46 indexed citations

20.

Stumpf, Craig R., et al.. (1997). Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract. Anti-Cancer Drugs. 8(Supplement 1). S23–S26. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact